Keurig Dr Pepper Reports Q1 2022 Results and Raises Full-Year Net Sales Guidance
Keurig Dr Pepper Inc. (KDP) reported Q1 2022 financial results, revealing a 6.1% increase in net sales to $3.08 billion, driven largely by strong growth in Packaged Beverages and Beverage Concentrates. The company raised its full-year net sales growth guidance to the high-single-digit range. Diluted EPS rose 78.3% to $0.41, though Adjusted EPS remained flat at $0.33. While operating income increased 51% to $966 million, inflation and supply chain disruptions affected margins. KDP maintains solid market share in cold beverages and aims for strong free cash flow management.
- Net sales grew 6.1% to $3.08 billion, driven by strong demand across business segments.
- Diluted EPS increased by 78.3% to $0.41, indicating strong profitability growth.
- Raised full-year net sales growth guidance to high-single-digit range.
- Operating income increased 51% to $966 million, reflecting solid revenue performance.
- Strong retail dollar consumption growth of 9.9% in Liquid Refreshment Beverages (LRB) category.
- Adjusted operating income declined 1.2% to $732 million, indicating pressure on profit margins.
- Coffee Systems net sales fell 4.3% due to supply chain disruptions.
- Broad-based inflation impacted margins, outpacing pricing actions taken.
Top-line Results Remain Strong, with Double-Digit Growth Reported in three Business Segments in Q1
Company also Reaffirms EPS Guidance for 2022
BURLINGTON, Mass. and FRISCO, Texas, April 28, 2022 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today reported financial results for the first quarter ended March 31, 2022 and raised its guidance for net sales growth in 2022 to the high-single-digit range, from the previous mid-single-digit range. The Company also reaffirmed its guidance for Adjusted EPS for the year.
Reported GAAP Basis | Adjusted Basis1 | ||
Q1 | Q1 | ||
Net Sales % vs Prior Year % vs 2020 | |||
Diluted EPS % vs Prior Year % vs 2020 |
Commenting on the announcement, Chairman and CEO Bob Gamgort stated, "We delivered another quarter of strong revenue growth, reflecting the power of our brand portfolio and the quality of our execution at retail. Margins were impacted by accelerating inflation, which outpaced the timing of pricing actions, and the previously discussed coffee supply chain disruption. We made significant progress during the quarter on increasing coffee production and rebuilding inventories, and we implemented additional pricing actions across most categories. Consequently, we now expect to deliver net sales growth in the high-single-digit range and continue to expect to deliver Adjusted EPS growth in the mid-single-digit range for the year."
First Quarter Consolidated Results
Net sales for the first quarter of 2022 increased
KDP in-market performance in the Liquid Refreshment Beverages (LRB) category remained strong in the quarter, with retail dollar consumption2 advancing
In coffee, retail dollar consumption of single-serve pods manufactured by KDP in IRi tracked channels increased
GAAP operating income increased
Adjusted operating income in the quarter declined
GAAP net income in the first quarter of 2022 increased
Adjusted net income advanced
Operating cash flow increased to
1 Adjusted financial metrics presented in this release are non-GAAP and on a constant currency basis. See reconciliations of GAAP results to Adjusted results on a constant currency basis in the accompanying tables.
2 Retail consumption data based on Keurig Dr Pepper's custom IRi category definitions for the 13-week period ending 3/27/2022.
3 CSDs refer to "Carbonated Soft Drinks".
Coffee Systems
Net sales for the first quarter of 2022 totaled
The higher net price realization in the quarter was driven by pricing actions taken late 2021 and in the first quarter of 2022, combined with sequentially lower customer fines incurred due to improving, but still somewhat challenged service levels.
The volume/mix decrease of
GAAP operating income declined
Adjusted operating income declined
Packaged Beverages
Net sales for the first quarter of 2022 increased an exceptionally strong
Leading the net sales performance were Canada Dry, Dr Pepper, 7UP, A&W, Sunkist and Squirt CSDs, Mott's, and Snapple, as well as growth in CORE Hydration, Polar seltzers, Hawaiian Punch and Vita Coco.
GAAP operating income increased
Adjusted operating income increased
Beverage Concentrates
Net sales for the first quarter of 2022 increased
Total shipment volume versus year-ago increased
GAAP operating income in the first quarter of 2022 increased
Adjusted operating income increased
Latin America Beverages
Net sales for the first quarter of 2022 increased
GAAP operating income in the first quarter of 2022 increased
Adjusted operating income increased
KDP 2022 Guidance
KDP raised its guidance for constant currency net sales growth in 2022 to the high-single-digit range and reaffirmed its guidance for Adjusted diluted EPS growth in 2022 in the mid-single-digit range. The Company continues to expect EPS performance versus 2021 to strengthen throughout the year, with Adjusted diluted EPS growth reaching the high-single-digit range in the second half of 2022, in line with the Company's long-term algorithm.
Investor Contacts:
Steve Alexander
T: 972-673-6769 / steve.alexander@kdrp.com
Media Contact:
Katie Gilroy
T: 781-418-3345 / katie.gilroy@kdrp.com
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue approaching
Certain statements contained herein are "forward-looking statements" within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as "outlook," "guidance," "anticipate," "expect," "believe," "could," "estimate," "feel," "forecast," "intend," "may," "plan," "potential," "project," "should," "target," "will," "would," and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially.
Forward-looking statements are subject to a number of risks and uncertainties, including the factors disclosed in our Annual Report on Form 10-K and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.
This release includes certain non-GAAP financial measures including Adjusted operating income, Adjusted net income, Adjusted diluted EPS, free cash flow and financial measures presented on a constant currency basis, which differ from results using U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures should be considered as supplements to the GAAP reported measures, should not be considered replacements for, or superior to, the GAAP measures and may not be comparable to similarly named measures used by other companies. Non-GAAP financial measures typically exclude certain charges, including one-time costs that are not expected to occur routinely in future periods. The Company uses non-GAAP financial measures internally to focus management on performance excluding these special charges to gauge our business operating performance. Management believes this information is helpful to investors because it increases transparency and assists investors in understanding the underlying performance of the Company and in the analysis of ongoing operating trends. Additionally, management believes that non-GAAP financial measures are frequently used by analysts and investors in their evaluation of companies, and their continued inclusion provides consistency in financial reporting and enables analysts and investors to perform meaningful comparisons of past, present and future operating results. The most directly comparable GAAP financial measures and reconciliations to non-GAAP financial measures are set forth in the appendix to this release and included in the Company's filings with the SEC.
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company's control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others.
KEURIG DR PEPPER INC. | ||||
First Quarter | ||||
(in millions, except per share data) | 2022 | 2021 | ||
Net sales | $ 3,078 | $ 2,902 | ||
Cost of sales | 1,428 | 1,302 | ||
Gross profit | 1,650 | 1,600 | ||
Selling, general and administrative expenses | 1,018 | 961 | ||
Gain on litigation settlement | (299) | — | ||
Other operating income, net | (35) | (1) | ||
Income from operations | 966 | 640 | ||
Interest expense | 188 | 140 | ||
Loss on early extinguishment of debt | 48 | 105 | ||
Gain on sale of equity method investment | (50) | — | ||
Impairment of investments and note receivable | 6 | — | ||
Other expense (income), net | 9 | (3) | ||
Income before provision for income taxes | 765 | 398 | ||
Provision for income taxes | 180 | 73 | ||
Net income including non-controlling interest | 585 | 325 | ||
Less: Net loss attributable to non-controlling interest | — | — | ||
Net income attributable to KDP | $ 585 | $ 325 | ||
Earnings per common share: | ||||
Basic | $ 0.41 | $ 0.23 | ||
Diluted | 0.41 | 0.23 | ||
Weighted average common shares outstanding: | ||||
Basic | 1,418.2 | 1,409.2 | ||
Diluted | 1,429.7 | 1,425.6 |
KEURIG DR PEPPER INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) | |||
March 31, | December 31, | ||
(in millions, except share and per share data) | 2022 | 2021 | |
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ 592 | $ 567 | |
Restricted cash and cash equivalents | 2 | 1 | |
Trade accounts receivable, net | 1,214 | 1,148 | |
Inventories | 1,045 | 894 | |
Prepaid expenses and other current assets | 637 | 447 | |
Total current assets | 3,490 | 3,057 | |
Property, plant and equipment, net | 2,436 | 2,494 | |
Investments in unconsolidated affiliates | 29 | 30 | |
Goodwill | 20,243 | 20,182 | |
Other intangible assets, net | 23,889 | 23,856 | |
Other non-current assets | 1,119 | 937 | |
Deferred tax assets | 38 | 42 | |
Total assets | $ 51,244 | $ 50,598 | |
Liabilities and Stockholders' Equity | |||
Current liabilities: | |||
Accounts payable | $ 4,510 | $ 4,316 | |
Accrued expenses | 1,028 | 1,110 | |
Structured payables | 143 | 142 | |
Short-term borrowings and current portion of long-term obligations | — | 304 | |
Other current liabilities | 767 | 613 | |
Total current liabilities | 6,448 | 6,485 | |
Long-term obligations | 11,584 | 11,578 | |
Deferred tax liabilities | 6,054 | 5,986 | |
Other non-current liabilities | 1,647 | 1,577 | |
Total liabilities | 25,733 | 25,626 | |
Commitments and contingencies | |||
Stockholders' equity: | |||
Preferred stock, | — | — | |
Common stock, | 14 | 14 | |
Additional paid-in capital | 21,764 | 21,785 | |
Retained earnings | 3,518 | 3,199 | |
Accumulated other comprehensive income (loss) | 215 | (26) | |
Total stockholders' equity | 25,511 | 24,972 | |
Non-controlling interest | — | — | |
Total equity | 25,511 | 24,972 | |
Total liabilities and stockholders' equity | $ 51,244 | $ 50,598 |
KEURIG DR PEPPER INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | |||
First Quarter | |||
(in millions) | 2022 | 2021 | |
Operating activities: | |||
Net income attributable to KDP | $ 585 | $ 325 | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation expense | 106 | 102 | |
Amortization of intangibles | 34 | 33 | |
Other amortization expense | 42 | 40 | |
Provision for sales returns | 12 | 19 | |
Deferred income taxes | 8 | 11 | |
Employee stock-based compensation (benefit) expense | (15) | 25 | |
Loss on early extinguishment of debt | 48 | 105 | |
Gain on sale of equity method investment | (50) | — | |
Gain on disposal of property, plant and equipment | (38) | (1) | |
Unrealized gain on foreign currency | (11) | (10) | |
Unrealized gain on derivatives | — | (41) | |
Equity in losses of unconsolidated affiliates | 3 | — | |
Impairment on investments and note receivable of unconsolidated affiliates | 6 | — | |
Other, net | 13 | 15 | |
Changes in assets and liabilities: | |||
Trade accounts receivable | (73) | (37) | |
Inventories | (147) | (77) | |
Income taxes receivable and payables, net | 135 | 25 | |
Other current and non-current assets | (284) | (295) | |
Accounts payable and accrued expenses | 151 | 121 | |
Other current and non-current liabilities | 138 | 186 | |
Net change in operating assets and liabilities | (80) | (77) | |
Net cash provided by operating activities | 663 | 546 | |
Investing activities: | |||
Proceeds from sale of investment in unconsolidated affiliates | 50 | — | |
Purchases of property, plant and equipment | (109) | (95) | |
Proceeds from sales of property, plant and equipment | 78 | 7 | |
Purchases of intangibles | (10) | (12) | |
Issuance of related party note receivable | (6) | — | |
Investments in unconsolidated affiliates | (3) | — | |
Other, net | 3 | 1 | |
Net cash provided by (used in) investing activities | 3 | (99) | |
Financing activities: | |||
Proceeds from issuance of Notes | — | 2,150 | |
Repayments of Notes | (201) | (1,845) | |
Proceeds from issuance of commercial paper | — | 120 | |
Repayments of commercial paper | (149) | (120) | |
Repayments of 2019 KDP Term Loan | — | (425) | |
Proceeds from structured payables | 38 | 35 | |
Repayments of structured payables | (37) | (41) | |
Cash dividends paid | (265) | (192) | |
Proceeds from issuance of common stock | — | 140 | |
Tax withholdings related to net share settlements | (5) | (125) | |
Payments on finance leases | (20) | (15) | |
Other, net | (5) | (37) | |
Net cash used in financing activities | (644) | (355) | |
Cash, cash equivalents, and restricted cash and cash equivalents: | |||
Net change from operating, investing and financing activities | 22 | 92 | |
Effect of exchange rate changes | 4 | 2 | |
Beginning balance | 568 | 255 | |
Ending balance | $ 594 | $ 349 |
KEURIG DR PEPPER INC. RECONCILIATION OF SEGMENT INFORMATION (UNAUDITED) | ||||
First Quarter | ||||
(in millions) | 2022 | 2021 | ||
Net Sales | ||||
Coffee Systems | $ 1,093 | $ 1,142 | ||
Packaged Beverages | 1,480 | 1,307 | ||
Beverage Concentrates | 359 | 328 | ||
Latin America Beverages | 146 | 125 | ||
Total net sales | $ 3,078 | $ 2,902 | ||
Income from Operations | ||||
Coffee Systems | $ 268 | $ 368 | ||
Packaged Beverages | 486 | 179 | ||
Beverage Concentrates | 244 | 238 | ||
Latin America Beverages | 25 | 22 | ||
Unallocated corporate costs | (57) | (167) | ||
Total income from operations | $ 966 | $ 640 |
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION
(UNAUDITED)
The company reports its financial results in accordance with U.S. GAAP. However, management believes that certain non-GAAP financial measures that reflect the way management evaluates the business may provide investors with additional information regarding the company's results, trends and ongoing performance on a comparable basis.
Specifically, investors should consider the following with respect to our financial results:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results, as well as the unrealized mark-to-market impact of our Vita Coco investment; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; (vi) non-cash changes in deferred tax liabilities related to goodwill and other intangible assets as a result of tax rate or apportionment changes; and (vii) other certain items that are excluded for comparison purposes to prior year periods.
For the first quarter of 2022, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic; (vi) the gain on the sale of our investment in BodyArmor; (vii) the gain on the settlement of our prior litigation with BodyArmor, excluding recoveries of previously incurred litigation expenses which were included in our adjusted results and (viii) losses recognized with respect to our equity method investment in Bedford as a result of funding our share of their wind-down costs.
For the first quarter of 2021, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic; and (vi) gains from insurance recoveries related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment.
Costs related to significant non-routine legal matters relate to the antitrust litigation. Incremental costs to our operations related to risks associated with the COVID-19 pandemic include incremental expenses incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic.
We believe removing these costs reflects how management views our business results on a consistent basis.
Constant currency adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability, calculated on a constant currency basis by converting our current period local currency financial results using the prior period foreign currency exchange rates.
For the first quarter of 2022 and 2021, the supplemental financial data set forth below includes reconciliations of adjusted and constant currency adjusted financial measures to the applicable financial measure presented in the unaudited condensed consolidated financial statements for the same period.
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN NON-GAAP INFORMATION (UNAUDITED) | |||||||||||||||
Cost of sales | Gross profit | Gross | Selling, general | Gain on | Other operating | Income from | Operating | ||||||||
For the First Quarter of 2022 | |||||||||||||||
Reported | $ 1,428 | $ 1,650 | 53.6 % | $ 1,018 | $ (299) | $ (35) | $ 966 | 31.4 % | |||||||
Items Affecting Comparability: | |||||||||||||||
Mark to market | 59 | (59) | 26 | — | — | (85) | |||||||||
Amortization of intangibles | — | — | (34) | — | — | 34 | |||||||||
Stock compensation | — | — | 7 | — | — | (7) | |||||||||
Restructuring and integration costs | — | — | (33) | — | (3) | 36 | |||||||||
Productivity | (28) | 28 | (22) | — | — | 50 | |||||||||
Non-routine legal matters | — | — | (4) | — | — | 4 | |||||||||
COVID-19 | (4) | 4 | (1) | — | — | 5 | |||||||||
Gain on litigation | — | — | — | 271 | — | (271) | |||||||||
Adjusted | $ 1,455 | $ 1,623 | 52.7 % | $ 957 | $ (28) | $ (38) | $ 732 | 23.8 % | |||||||
Impact of foreign currency | — % | — % | |||||||||||||
Constant currency adjusted | 52.7 % | 23.8 % | |||||||||||||
For the First Quarter of 2021 | |||||||||||||||
Reported | $ 1,302 | $ 1,600 | 55.1 % | $ 961 | $ — | $ (1) | $ 640 | 22.1 % | |||||||
Items Affecting Comparability: | |||||||||||||||
Mark to market | 9 | (9) | 29 | — | — | (38) | |||||||||
Amortization of intangibles | — | — | (33) | — | — | 33 | |||||||||
Stock compensation | — | — | (6) | — | — | 6 | |||||||||
Restructuring and integration costs | — | — | (43) | — | — | 43 | |||||||||
Productivity | (8) | 8 | (25) | — | — | 33 | |||||||||
Non-routine legal matters | — | — | (10) | — | — | 10 | |||||||||
COVID-19 | (12) | 12 | (4) | — | — | 16 | |||||||||
Malware incident | — | — | 2 | — | — | (2) | |||||||||
Adjusted | $ 1,291 | $ 1,611 | 55.5 % | $ 871 | $ — | $ (1) | $ 741 | 25.5 % |
Refer to page A-8 for reconciliations of reported net sales to constant currency net sales and adjusted income from operations to constant currency adjusted income from operations. |
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN NON-GAAP INFORMATION (UNAUDITED) | |||||||||||||||||||
Interest | Loss on early | Gain on sale | Impairment of | Other | Income | Provision | Effective | Net | Diluted | ||||||||||
For the First Quarter of 2022 | |||||||||||||||||||
Reported | $ 188 | $ 48 | $ (50) | $ 6 | $ 9 | $ 765 | $ 180 | 23.5 % | $ 585 | $ 0.41 | |||||||||
Items Affecting Comparability: | |||||||||||||||||||
Mark to market | (71) | — | — | — | (3) | (11) | (2) | (9) | (0.01) | ||||||||||
Amortization of intangibles | — | — | — | — | — | 34 | 9 | 25 | 0.02 | ||||||||||
Amortization of deferred financing costs | (1) | — | — | — | — | 1 | — | 1 | — | ||||||||||
Amortization of fair value debt adjustment | (5) | — | — | — | — | 5 | 1 | 4 | — | ||||||||||
Stock compensation | — | — | — | — | — | (7) | (1) | (6) | — | ||||||||||
Restructuring and integration costs | — | — | — | — | — | 36 | 9 | 27 | 0.02 | ||||||||||
Productivity | — | — | — | — | — | 50 | 12 | 38 | 0.03 | ||||||||||
Impairment of investment | — | — | — | (6) | 6 | — | 6 | — | |||||||||||
Loss on early extinguishment of debt | — | (48) | — | — | — | 48 | 11 | 37 | 0.03 | ||||||||||
Non-routine legal matters | — | — | — | — | — | 4 | 1 | 3 | — | ||||||||||
COVID-19 | — | — | — | — | — | 5 | 1 | 4 | — | ||||||||||
Gain on litigation | — | — | — | — | — | (271) | (68) | (203) | (0.14) | ||||||||||
Gain on sale of equity-method investment | — | — | 50 | — | — | (50) | (12) | (38) | (0.03) | ||||||||||
Adjusted | $ 111 | $ — | $ — | $ — | $ 6 | $ 615 | $ 141 | 22.9 % | $ 474 | $ 0.33 | |||||||||
Impact of foreign currency | — % | ||||||||||||||||||
Constant currency adjusted | 22.9 % | ||||||||||||||||||
For the First Quarter of 2021 | |||||||||||||||||||
Reported | $ 140 | $ 105 | $ — | $ — | $ (3) | $ 398 | $ 73 | 18.3 % | $ 325 | $ 0.23 | |||||||||
Items Affecting Comparability: | |||||||||||||||||||
Mark to market | 8 | — | — | — | — | (46) | (11) | (35) | (0.02) | ||||||||||
Amortization of intangibles | — | — | — | — | — | 33 | 8 | 25 | 0.02 | ||||||||||
Amortization of deferred financing costs | (3) | — | — | — | — | 3 | — | 3 | — | ||||||||||
Amortization of fair value of debt adjustment | (6) | — | — | — | — | 6 | 2 | 4 | — | ||||||||||
Stock compensation | — | — | — | — | — | 6 | 12 | (6) | — | ||||||||||
Restructuring and integration costs | — | — | — | — | — | 43 | 11 | 32 | 0.02 | ||||||||||
Productivity | — | — | — | — | — | 33 | 8 | 25 | 0.02 | ||||||||||
Loss on early extinguishment of debt | — | (105) | — | — | — | 105 | 25 | 80 | 0.06 | ||||||||||
Non-routine legal matters | — | — | — | — | — | 10 | 2 | 8 | 0.01 | ||||||||||
COVID-19 | — | — | — | — | — | 16 | 4 | 12 | 0.01 | ||||||||||
Malware incident | — | — | — | — | — | (2) | — | (2) | — | ||||||||||
Adjusted | $ 139 | $ — | $ — | $ — | $ (3) | $ 605 | $ 134 | 22.1 % | $ 471 | $ 0.33 | |||||||||
Change - adjusted | (20.1) % | 0.6 % | — % | ||||||||||||||||
Impact of foreign currency | — % | 0.2 % | — % | ||||||||||||||||
Change - Constant currency adjusted | (20.1) % | 0.8 % | — % |
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN FINANCIAL MEASURES BY SEGMENT TO CONSTANT CURRENCY
(UNAUDITED) | ||||||||||||||
(in millions) | Reported | Items Affecting | Adjusted | |||||||||||
For the first quarter of 2022: | ||||||||||||||
Income from operations | ||||||||||||||
Coffee Systems | $ 268 | $ 51 | $ 319 | |||||||||||
Packaged Beverages | 486 | (251) | 235 | |||||||||||
Beverage Concentrates | 244 | 3 | 247 | |||||||||||
Latin America Beverages | 25 | 1 | 26 | |||||||||||
Unallocated corporate costs | (57) | (38) | (95) | |||||||||||
Total income from operations | $ 966 | $ (234) | $ 732 | |||||||||||
For the first quarter of 2021: | ||||||||||||||
Income from operations | ||||||||||||||
Coffee Systems | $ 368 | $ 53 | $ 421 | |||||||||||
Packaged Beverages | 179 | 22 | 201 | |||||||||||
Beverage Concentrates | 238 | 1 | 239 | |||||||||||
Latin America Beverages | 22 | 1 | 23 | |||||||||||
Unallocated corporate costs | (167) | 24 | (143) | |||||||||||
Total income from operations | $ 640 | $ 101 | $ 741 | |||||||||||
Reported | Impact of Foreign | Constant Currency | ||||||||||||
For the first quarter of 2022: | ||||||||||||||
Net sales | ||||||||||||||
Coffee Systems | (4.3) % | — % | (4.3) % | |||||||||||
Packaged Beverages | 13.2 | — | 13.2 | |||||||||||
Beverage Concentrates | 9.5 | — | 9.5 | |||||||||||
Latin America Beverages | 16.8 | 0.8 | 17.6 | |||||||||||
Total net sales | 6.1 | — | 6.1 | |||||||||||
Adjusted | Impact of Foreign | Constant Currency | ||||||||||||
For the first quarter of 2022: | ||||||||||||||
Income from operations | ||||||||||||||
Coffee Systems | (24.2) % | — % | (24.2) % | |||||||||||
Packaged Beverages | 16.9 | — | 16.9 | |||||||||||
Beverage Concentrates | 3.3 | — | 3.3 | |||||||||||
Latin America Beverages | 13.0 | — | 13.0 | |||||||||||
Total income from operations | (1.2) | — | (1.2) | |||||||||||
Reported | Items Affecting | Adjusted | Impact of Foreign | Constant Currency | ||||||
For the first quarter of 2022: | ||||||||||
Operating margin | ||||||||||
Coffee Systems | 24.5 % | 4.7 % | 29.2 % | — % | 29.2 % | |||||
Packaged Beverages | 32.8 | (16.9) | 15.9 | — | 15.9 | |||||
Beverage Concentrates | 68.0 | 0.8 | 68.8 | — | 68.8 | |||||
Latin America Beverages | 17.1 | 0.7 | 17.8 | (0.1) | 17.7 | |||||
Total operating margin | 31.4 | (7.6) | 23.8 | — | 23.8 |
KEURIG DR PEPPER INC. RECONCILIATION OF ADJUSTED EBITDA AND MANAGEMENT LEVERAGE RATIO (UNAUDITED) | |
(in millions, except for ratio) | |
ADJUSTED EBITDA RECONCILIATION - LAST TWELVE MONTHS | |
Net income attributable to KDP | $ 2,406 |
Interest expense | 548 |
Provision for income taxes | 760 |
Other (income) expense, net | 10 |
Depreciation expense | 414 |
Other amortization | 166 |
Amortization of intangibles | 135 |
EBITDA | $ 4,439 |
Items affecting comparability: | |
Gain on sale of equity-method investment | $ (574) |
Gain on litigation settlement | (271) |
Loss on early extinguishment of debt | 48 |
Impairment of investments and note receivable | 23 |
Restructuring and integration expenses | 192 |
Productivity | 155 |
Non-routine legal matters | 24 |
Stock compensation | 5 |
COVID-19 | 26 |
Transaction costs | 2 |
Mark to market | (104) |
Adjusted EBITDA | $ 3,965 |
March 31, | |
2022 | |
Principal amounts of senior unsecured notes | $ 11,750 |
Less: Cash and cash equivalents | 592 |
Total principal amounts less cash and cash equivalents | $ 11,158 |
March 31, 2022 Management Leverage Ratio | 2.8 |
KEURIG DR PEPPER INC. RECONCILIATION OF ADJUSTED EBITDA - LAST TWELVE MONTHS (UNAUDITED) | |||||||||
(in millions) | SECOND | THIRD | FOURTH | FIRST | LAST | ||||
Net income attributable to KDP | $ 448 | $ 530 | $ 843 | $ 585 | $ 2,406 | ||||
Interest expense | 125 | 116 | 119 | 188 | 548 | ||||
Provision for income taxes | 165 | 149 | 266 | 180 | 760 | ||||
Other (income) expense, net | (4) | 1 | 4 | 9 | 10 | ||||
Depreciation expense | 104 | 98 | 106 | 106 | 414 | ||||
Other amortization | 40 | 38 | 46 | 42 | 166 | ||||
Amortization of intangibles | 34 | 34 | 33 | 34 | 135 | ||||
EBITDA | $ 912 | $ 966 | $ 1,417 | $ 1,144 | $ 4,439 | ||||
Items affecting comparability: | |||||||||
Gain on sale of equity-method investment | $ — | $ — | $ (524) | $ (50) | $ (574) | ||||
Gain on litigation settlement | — | — | — | (271) | (271) | ||||
Loss on early extinguishment of debt | — | — | — | 48 | 48 | ||||
Impairment on investments and note receivable | — | — | 17 | 6 | 23 | ||||
Restructuring and integration expenses | 49 | 53 | 57 | 33 | 192 | ||||
Productivity | 32 | 40 | 40 | 43 | 155 | ||||
Nonroutine legal matters | 6 | 7 | 7 | 4 | 24 | ||||
Stock compensation | 5 | 3 | 4 | (7) | 5 | ||||
COVID-19 | 11 | 4 | 6 | 5 | 26 | ||||
Transaction costs | — | 1 | 1 | — | 2 | ||||
Malware incident | — | (1) | 1 | — | — | ||||
Mark to market | (38) | (9) | 28 | (85) | (104) | ||||
Adjusted EBITDA | $ 977 | $ 1,064 | $ 1,054 | $ 870 | $ 3,965 |
KEURIG DR PEPPER INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(UNAUDITED)
Free cash flow is defined as net cash provided by operating activities adjusted for purchases of property, plant and equipment, proceeds from sales of property, plant and equipment, and certain items excluded for comparison to prior year periods. For the first quarter of 2022 and 2021, there were no certain items excluded for comparison to prior year periods.
First Quarter | ||||
(in millions) | 2022 | 2021 | ||
Net cash provided by operating activities | $ 663 | $ 546 | ||
Purchases of property, plant and equipment | (109) | (95) | ||
Proceeds from sales of property, plant and equipment | 78 | 7 | ||
Free Cash Flow | $ 632 | $ 458 |
KEURIG DR PEPPER INC.
RECONCILIATION OF SIGNIFICANT COVID-19 RELATED EXPENSES
(UNAUDITED)
The following table sets forth our reconciliation of significant COVID-19-related expenses. However, employee compensation expense and employee protection costs, which impact our SG&A expenses and cost of sales, are included as the COVID-19 item affecting comparability and are excluded in our Adjusted financial measures. In addition, reported amounts under U.S. GAAP also include additional costs, not included as the COVID-19 item affecting comparability, as presented in tables below.
Items Affecting Comparability(1) | |||||
(in millions) | Employee | Employee | Total | ||
For the first quarter of 2022: | |||||
Coffee Systems | $ 1 | $ 2 | $ 3 | ||
Packaged Beverages | 1 | 1 | 2 | ||
Beverage Concentrates | — | — | — | ||
Latin America Beverages | — | — | — | ||
Total | $ 2 | $ 3 | $ 5 | ||
For the first quarter of 2021: | |||||
Coffee Systems | $ 1 | $ 9 | $ 10 | ||
Packaged Beverages | 3 | 2 | 5 | ||
Beverage Concentrates | — | — | — | ||
Latin America Beverages | — | 1 | 1 | ||
Total | $ 4 | $ 12 | $ 16 | ||
(1) | Employee compensation expense and employee protection costs are both included as the COVID-19 items affecting comparability in the reconciliation of our Adjusted Non-GAAP financial measures. |
(2) | Primarily included incremental benefits provided to frontline workers such as extended sick leave, in order to maintain essential operations during the COVID-19 pandemic. |
(3) | Included costs associated with personal protective equipment, temperature scans, cleaning and other sanitization services. Impacts both cost of sales and SG&A expenses. |
RECONCILIATION OF CERTAIN ADJUSTED AND CONSTANT CURRENCY ADJUSTED FINANCIAL RESULTS
FOR THE FIRST QUARTER OF 2020
(Unaudited, in millions, except per share data)
For the purposes of additional analysis, we have also included certain non-GAAP financial measures for the first quarter of 2020.
For the first quarter of 2020, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; and (vi) other certain items that are excluded for comparison purposes to prior year periods.
For the first quarter of 2020, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) not associated with the DPS Merger; (iv) costs related to significant non-routine legal matters; (v) the impact of the step-up of acquired inventory not associated with the DPS Merger (vi) incremental costs to our operations related to risks associated with the COVID-19 pandemic and (vii) impairment recognized on equity method investment with Bedford Systems, LLC.
Net Sales | Income from operations | Diluted earnings per share(1) | ||||
Reported | $ 2,613 | $ 466 | $ 0.11 | |||
Items Affecting Comparability: | ||||||
Mark to market | — | 58 | 0.04 | |||
Amortization of intangibles | — | 33 | 0.02 | |||
Stock compensation | — | 7 | — | |||
Restructuring and integration costs | — | 52 | 0.03 | |||
Productivity | — | 54 | 0.03 | |||
Impairment on investment | — | — | 0.05 | |||
Nonroutine legal matters | — | 9 | — | |||
COVID-19 | — | 5 | — | |||
Adjusted | $ 2,613 | $ 684 | $ 0.29 |
(1) | Diluted earnings per share may not foot due to rounding. |
RECONCILIATION OF CERTAIN ADJUSTED AND CONSTANT CURRENCY ADJUSTED FINANCIAL RESULTS
FOR THE FIRST QUARTER OF 2020
(Unaudited, in millions, except per share data)
Constant currency adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability, calculated on a Constant currency basis by converting our current period local currency financial results using the prior period foreign currency exchange rates.
Growth (%) | ||||||
Net sales growth compared to the first quarter of 2020 | 17.8 % | |||||
Impact of foreign currency | (0.3) | |||||
Constant currency net sales growth compared to the first quarter of 2020 | 17.5 % | |||||
Adjusted income from operations growth compared to the first quarter of 2020 | 7.0 % | |||||
Impact of foreign currency | (0.3) % | |||||
Constant currency adjusted income from operations growth compared to the first quarter of 2020 | 6.7 % | |||||
Adjusted diluted earnings per share growth compared to the first quarter of 2020 | 13.8 % | |||||
Impact of foreign currency | — % | |||||
Constant currency adjusted diluted earnings per share growth compared to the first quarter of 2020 | 13.8 % | |||||
Reported | Impact of Foreign | Constant Currency | ||||
For the first quarter of 2022: | ||||||
Net sales | ||||||
Coffee Systems | 12.3 % | (0.5) % | 11.8 % | |||
Packaged Beverages | 21.6 | (0.2) | 21.4 | |||
Beverage Concentrates | 17.3 | (0.6) | 16.7 | |||
Latin America Beverages | 24.8 | 1.7 | 26.5 | |||
Total net sales | 17.8 | (0.3) | 17.5 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/keurig-dr-pepper-reports-q1-2022-results-and-raises-full-year-net-sales-guidance-301534820.html
SOURCE Keurig Dr Pepper Inc.
FAQ
What were Keurig Dr Pepper's Q1 2022 financial results?
How did KDP perform in the Liquid Refreshment Beverages market?
What is KDP's guidance for net sales growth in 2022?
What factors affected KDP's profit margins in Q1 2022?